China Oncology ›› 2016, Vol. 26 ›› Issue (8): 712-720.doi: 10.19401/j.cnki.1007-3639.2016.08.012

Previous Articles    

XU Binghe1, SHAO Zhimin2, HU Xichun3, JIANG Zefei4   

  1. 1.Department of Oncology, Cancer Hospital, Chinese Academy of Medical Sciences, Beijing 100021, China; 2. Department of Breast Surgery, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China; 3. Department of Medical Oncology, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University, Shanghai 200032, China; 4. Department of Brest Cancer, Affiliated Hospital of Academy of Military Medical Sciences, Beijing 100071, China
  • Online:2016-08-30 Published:2016-10-19

Key words: Breast cancer, Ovarian function suppression, Endocrine therapy